By Sian Lazell
February 17, 2017
Ceva Animal Health is set to begin US commercialization of its Catego antiparasitic through Amazon in mid-February 2017.
In addition, all PetSmart stores in the US will stock Catego from March. Independent pet stores will also be able to market the product.
Ceva initially launched Catego in the US in November 2016. The product is a fast-acting topical flea and tick treatment specifically for cats, containing the active ingredients dinotefuran, fipronil and pyriproxyfen.
Catego is indicated to kill fleas within six hours, with 97% efficacy within three hours on the day of application. Ceva said Catego is twice as fast at killing fleas than Merial's Frontline Plus and Bayer Animal Health's Advantage II. The firm added Catego not only kills adult fleas but it also breaks the life cycle, protecting against multiple stages of the flea cycle and flea re-infestation.
Catego is additionally indicated to kill ticks in all stages of life on contact, before they can bite. The product provides protection against tick species including: brown dog ticks (Rhipicephalus sanguineus); American dog ticks (Dermacentor variabilis); lone star ticks (Amblyomma americanum); and deer ticks (Ixodes scapularis).
The antiparasitic is designed for all cats weighing more than 1.5 pounds and over eight weeks of age. It is available in three- and six-dose cards, with each dose effective for one month.
Elizabeth Hodgkins, director of veterinary relations at Ceva Animal Health, said: "Catego gives pet owners a powerful formulation to help better protect their cats from harmful pests. Its ability to kill and control fleas and ticks, combined with its easy application, give pet owners a new standard of care in protecting their beloved cats."
Ceva Animal Health is the US branch of French firm Ceva Santé Animale. The company recently recorded full-year growth of 6%, showing promising growth across all its international markets as it works towards its goal of becoming a top five animal health player by 2020.